VAJRO, Pietro
 Distribuzione geografica
Continente #
NA - Nord America 28.058
AS - Asia 15.433
EU - Europa 8.342
SA - Sud America 1.062
Continente sconosciuto - Info sul continente non disponibili 658
AF - Africa 178
OC - Oceania 17
Totale 53.748
Nazione #
US - Stati Uniti d'America 27.731
HK - Hong Kong 6.615
SG - Singapore 3.854
IT - Italia 3.313
CN - Cina 2.211
UA - Ucraina 1.697
VN - Vietnam 1.018
BR - Brasile 805
DE - Germania 749
RU - Federazione Russa 578
IE - Irlanda 530
FR - Francia 454
FI - Finlandia 369
IL - Israele 369
KR - Corea 363
TR - Turchia 325
SE - Svezia 227
CA - Canada 188
IN - India 186
GB - Regno Unito 133
AR - Argentina 107
MX - Messico 82
BD - Bangladesh 77
JP - Giappone 61
IQ - Iraq 60
PL - Polonia 58
ES - Italia 48
ZA - Sudafrica 48
EU - Europa 47
PK - Pakistan 46
AT - Austria 45
ID - Indonesia 43
EC - Ecuador 39
NL - Olanda 39
VE - Venezuela 36
UZ - Uzbekistan 26
CO - Colombia 24
SA - Arabia Saudita 24
TN - Tunisia 24
MY - Malesia 22
PH - Filippine 20
EG - Egitto 19
MA - Marocco 16
CL - Cile 15
CZ - Repubblica Ceca 15
ET - Etiopia 15
PY - Paraguay 15
AE - Emirati Arabi Uniti 14
DZ - Algeria 14
KE - Kenya 14
AU - Australia 13
IR - Iran 13
JO - Giordania 11
LT - Lituania 11
CR - Costa Rica 10
NP - Nepal 10
RO - Romania 10
AL - Albania 9
AZ - Azerbaigian 9
JM - Giamaica 8
OM - Oman 8
PE - Perù 8
BY - Bielorussia 7
GR - Grecia 7
HN - Honduras 7
UY - Uruguay 7
KZ - Kazakistan 6
LB - Libano 6
BO - Bolivia 5
DK - Danimarca 5
LC - Santa Lucia 5
PT - Portogallo 5
BA - Bosnia-Erzegovina 4
CH - Svizzera 4
KG - Kirghizistan 4
KW - Kuwait 4
LU - Lussemburgo 4
NZ - Nuova Zelanda 4
PA - Panama 4
PR - Porto Rico 4
AO - Angola 3
BB - Barbados 3
GT - Guatemala 3
HU - Ungheria 3
MN - Mongolia 3
PS - Palestinian Territory 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
AF - Afghanistan, Repubblica islamica di 2
BE - Belgio 2
BN - Brunei Darussalam 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GE - Georgia 2
HR - Croazia 2
MD - Moldavia 2
MQ - Martinica 2
Totale 53.091
Città #
Hong Kong 6.594
Ann Arbor 5.988
Woodbridge 2.961
Wilmington 2.672
Singapore 2.124
Jacksonville 2.053
Houston 1.699
San Jose 1.654
Chandler 1.531
Princeton 1.425
Milan 1.315
Dallas 937
Ashburn 922
Council Bluffs 643
Dublin 522
Dong Ket 407
Beijing 398
Lauterbourg 372
Nanjing 365
The Dalles 361
Andover 354
Dearborn 349
Boardman 305
Rome 296
Pellezzano 286
Izmir 277
Mestre 277
Düsseldorf 223
Ho Chi Minh City 197
Moscow 158
Hanoi 155
Salerno 142
Santa Clara 140
Fairfield 130
Los Angeles 130
Shenyang 124
Nanchang 119
Changsha 116
Hebei 114
New York 103
Jiaxing 102
São Paulo 94
Naples 86
Tianjin 86
Figino 80
Norwalk 79
Ottawa 64
Tokyo 57
Brooklyn 53
Orem 52
Turin 50
Jinan 49
Warsaw 49
Seattle 44
Atlanta 42
Frankfurt am Main 42
Mexico City 39
Munich 39
Washington 39
Johannesburg 37
Chicago 36
San Diego 36
Chennai 35
Phoenix 35
San Francisco 35
Stockholm 35
Guangzhou 32
Montreal 32
Denver 30
London 30
Cambridge 29
Vienna 29
Boston 28
Manchester 28
Columbus 27
Nuremberg 27
Redwood City 27
Rio de Janeiro 27
Haiphong 26
Pune 26
Belo Horizonte 24
Da Nang 24
Helsinki 23
Baghdad 22
Shanghai 22
Tashkent 22
Amsterdam 21
Hangzhou 20
Charlotte 19
Toronto 18
Venezia 18
Falls Church 17
Jakarta 17
Kunming 17
Seoul 17
Ankara 16
Dormagen 16
Hefei 16
Napoli 16
Springfield 16
Totale 41.112
Nome #
Clinical features and genotype-phenotype correlations in children withprogressive familial intrahepatic cholestasis type 3 related to ABCB4 mutations. 810
Hepatitis B virus and the paediatric liver: waiting for news on the horizon 744
Efficacy of a multi-compartmental obesity prevention program (the 3P Project) in South Italy preschoolers 607
Migrazione sanitaria pediatrica: analisi epidemiologica, statistica, sociale ed economica del fenomeno in Campania 548
Characterization and burden of Campania children health migration across Italian regions during years 2006–2010: chance and/or necessity? 491
Autoimmune liver disease associated with celiac disease in childhood: a multicenter study 484
Brain abscess due to Klebsiella Pneumoniae in liver-transplanted children 397
Pediatric liver diseases and ocular changes: What hepatologists and ophthalmologists should know and share with each other 369
Celiac Disease-Associated Autoimmune Hepatitis In Childhood: Long Term Response To Treatment 343
Multiple gut-liver axis abnormalities in children with obesity with and without hepatic involvement 339
Recombinant interferon-alfa therapy in children with chronic hepatitis C 328
Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment. 317
Thyroid dysfunction and its role as a risk factor for non-alcoholic fatty liver disease: What's new 260
A systematic review of pediatrics NAFLD therapy: year 2012 251
Evaluation of hyaluronic acid (HA) and laminin (LAM) serum levels as quantitative markers of histomorphometry-proven liver fibrosis in children with chronic B hepatitis. 247
Metabolomic salivary signature of pediatric obesity related liver disease and metabolic syndrome 240
Guidelines for the screening and follow-up of infants born to anti-HCV positive mothers. 234
Prevalence and long term follow up of macroaspartate aminotransferase (macroAST) in children. 215
Maternal microbiota, prepregnancy weight, and mode of delivery: Intergenerational transmission of risk for childhood overweight and obesity 213
Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. 212
Alterations of the autoimmune regulator transcription factor and failure of central tolerance: APECED as a model. 211
Self-concept and psychopatological risk in liver transplantated children. 208
Fas apo1 mutations and defective Fas-mediated apoptosis in a child with type 2a autoimmune hepatitis 206
Probiotics Reduce the Inflammatory Response Induced by a High-Fat Diet in theLiver of Young Rats 205
Ipertransaminasemia cronica idiopatica 199
"Classic" and "new" prothrombotic risk factors in children with portal vein thrombosis. 196
Urinary Metabolomics in Pediatric Obesity and NAFLD Identifies Metabolic Pathways/Metabolites Related to Dietary Habits and Gut-Liver Axis Perturbations. 196
Humanization interventions in general pediatric wards: a systematic review 196
Twenty-four novel mutations in Wilson disease patients of predominantly Italian origin 194
A NEW POSSIBLE THERAPEUTIC STRATEGY IN OBESITYRELATED LIVER DISEASE: PRELIMINARY DATA WITH LACTOBACILLUS RHAMNOSUS STRAIN GG 193
Pharmacological interventions for nonalcoholic fatty liver disease in adults and in children: a systematic review 189
Low rate sustained response to IFN therapy in children with chronic hepatitis C (CHC) 189
A 360-Degree Overview Of Paediatric Nafld: Recent Insights 189
Deficit staturo-ponderale nel bambino: non sempre un problema esclusivamente endocrinologico. 189
Management of adults with paediatric-onset chronic liver disease: Strategic issues for transition care 189
Hepatic Presentation of Late-Onset Multiple Acyl-CoA Dehydrogenase Deficiency (MADD): Case Report and Systematic Review 188
Genotype-phenotype correlation in Italian children with Wilson Disease 186
Jagged-1 mutation analysis in Italian Alagille syndrome patients. 181
Atypical celiac disease presenting as obesity-related liver dysfunction. 179
MITOCHONDRIAL DYSFUNCTION AND AUTOIMMUNITY PHENOMENA IN SHWACHMAN-DIAMOND SYNDROME RELATED LIVER DISEASE. 177
Diagnosis of hepatopulmonary sindrome (HPS) in children with chronic liver disease (CLD) 176
The canine copper toxicosis gene MURR1 is not implicated in thepathogenesis of Wilson disease. 173
Brain abscess due to Klebsiella pneumoniae in a liver-transplanted child 171
Antioxidant vitamin E for the treatment of obesità related liver dysfunction in children with poor compliance to hypocaloric diets 171
Pediatric Celiac Disease, Cryptogenic Hypertransaminasemia, and Autoimmune Hepatitis. 170
A practical approach to the child with abnormal liver tests. 170
Italian experience of pediatric liver transplantation 168
Spectrum of UGT1A1 mutations in Crigler-Najjar (CN) syndrome patients: identification of twelve novel alleles and genotype-phenotype correlation. 165
LONG-TERM ZINC THERAPY IN WILSON DISEASE CHILDREN WITH MILD LIVER DISEASE 164
An epidemiological survey of hepatitis C virus infection in Italian children in the decade 1990-1999 164
Autoimmune liver disorders and coeliac disease in children: the SIGEP CALD study 161
Textbook of liver transplatation. Transition to Adult Care: Adolescents Care 160
Aagenaes's syndrome in an Italian child. 160
Autoimmune liver disorders and celiac dsease in children: the SIGEP CALD study 159
Celiac disease-related hepatic injury: Insights into associated conditions and underlying pathomechanisms 159
Congenital hepatic shunts: a pediatric series. 158
Alagille syndrome: An overview. 158
Systematic review and meta-analysis of the association celia disease-liver disease in the pediatric age 158
‘3P (Preschool Prevention Program)’: Preliminary Results Of A Pilot Project For Early Obesity Prevention And Mediterranean Diet Promotion 157
Early detection of post-transplant lymphoproliferative disorders (PTLD) and modulation of immune suppression (IS) in liver transplant recipients by means of EBNA 1 and BZLF1 expression monitoring 157
Autoimmune manifestations in pediatric liver transplantation recipients 157
A comparison of toddlers milk: are all the same? 157
Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions 156
Autoantibodies against CYP-2C19: A Novel Serum Marker in Pediatric De Novo Autoimmune Hepatitis? 156
Ophthalmological findings of phenylketonuria: a survey of 14 cases. 155
Health-related quality of life in pediatric liver transplanted patients compared with a chronic liver disease group. 155
IFN in pedaitric chronic hepatitis B (CHB). 153
Diagnosis of nonalcoholic fatty liver disease inchildren and adolescents: position paper of the ESPGHAN Hepatology Committee 152
Indications and Limitations of Bariatric Intervention in Severely Obese Children and Adolescents With and Without Non-alcoholic Steatohepatitis: the ESPGHAN Hepatology Committee Position Statement 151
Zinc monotherapy is effective in Wilson's disease patients with mild liver disease diagnosed in childhood: a retrospective study. 151
Noninvasive investigation of hepatopulmonary syndrome in children and adolescents with chronic cholestasis. 149
Serum Transaminases in Children with Wilson's Disease. 149
Orocoecal transit time in healthy and constipated children. 149
Multiple phenotypes in phosphoglucomutase 1 deficiency. 149
A case of galactosemia misdiagnosed as cow's milk intolerance 148
POST-TRANSPLANT ERYTHROCYTOSIS IN PEDIATRIC LIVER RECIPIENTS: GENETIC ABNORMALITIES OF OXIGEN SENSING PATHWAY, ERYTHROPOIETIN AND JAK2 ARE NOT INVOLVED IN ITS PATHOGENESIS 147
YEAR 2010: SYSTEMATIC REVIEW OF TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN CHILDREN AND ADOLESCENTS 147
Mutations of ABCB4 gene in children with progressive familial intrahepatic cholestasis: a multicenter Italian study. 146
Posttransfusion and community-acquired hepatitis C in childhood. 146
Probiotics in the treatment of Non Alcoholic Fatty Liver Disease: Further evidence in obese children 146
Infection with the delta agent in children 145
LACTOBACILLUS RHAMNOSUS STRAIN GG DESERVES CONSIDERATION AS A THERAPEUTIC TOOL IN OBESITY-RELATED LIVER DISEASE 145
ASYMPTOMATIC HYPERTRANSAMINASEMIA: A STILL POORLY RECOGNIZED MARKER OF EARLY DUCHENNE/BECKER MUSCULAR DYSTROPHY 144
Long-term response to IFN therapy in children with chronic hepatitis C. 144
Breast feeding enhances the clearance of HBsAg in infants with hepatitis B virus infection. 144
Nutritional problems in children with neuromotor disabilities: an Italian case series. 144
Analisi gascromatografica dell'ossido di carbonio nell'aria espirata: possibile applicazione nel controllo del livello di esposizione al CO. 143
EBNA1 and BZLF1 plus IgG serum levels individuate early stages of Epstein-Barr Virus (EBV)-related post-transplant lymphoproliferative disease (PTLD) and helps modulation of immmunosuppression (IS) in liver transplant recipients. 143
Salivary markers of hepato-metabolic comorbidities in pediatric obesity 143
Relations of gut liver axis components and gut microbiota in obese children with fatty liver: A pilot study 143
Hypertransaminasemia and coeliac disease 142
Epidemiological profile of 806 Italian children with hepatitis C virus infection over a 15-year period 142
Metabolic, hormonal, oxidative, and inflammatory factors in pediatricobesity-related liver disease 142
Autoimmune manifestations in children transplanted for non-autoimmune liver diseases 142
Novel congenital disorders of glycosylation may underlie cryptogenic liver disease in children. 141
Analgesic effects of breast- and formula feeding during routine childhood immunizations up to 1 year of age 141
COACH syndrome: report of two brothers with congenital hepatic fibrosis, cerebellar vermis hypoplasia, oligophrenia, ataxia, and mental retardation. 140
Volume and emptying of the gallbladder in patients with cystic fibrosis 140
Pediatric non-alcoholic fatty liver disease: Recent advances. 140
Cytochrome 2C19: a New Hepatic Target of Immune Reactions After Orthopic Liver Transplantation. 139
Totale 20.654
Categoria #
all - tutte 154.864
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 154.864


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.411 0 0 6 27 64 31 22 104 394 334 319 1.110
2022/20233.881 430 136 82 409 621 859 5 366 698 20 171 84
2023/20241.553 143 306 99 76 96 163 66 84 19 80 81 340
2024/20253.441 184 86 112 140 118 547 472 403 423 191 370 395
2025/202619.105 1.031 3.749 3.657 544 1.568 797 2.913 517 743 1.415 180 1.991
2026/2027794 374 316 104 0 0 0 0 0 0 0 0 0
Totale 53.748